Inherited Cardiac Conditions: Comparing Expert Approaches to Family Screening Duty in Fatal Claims

In medico-legal practice involving sudden cardiac death, inherited cardiac conditions such as hypertrophic cardiomyopathy (HCM), long QT syndrome (LQTS), and arrhythmogenic right ventricular cardiomyopathy (ARVC) frequently form the basis of claims alleging breach of duty in family screening and genetic testing referrals. The duty to identify at-risk relatives following a sudden death—particularly where an inherited condition is suspected—has become a critical focus in catastrophic and fatal claims. For solicitors navigating these cases, understanding how cardiology expert witnesses evaluate the alleged failure to initiate cascade screening can be pivotal in assessing breach, causation, and quantum.

Clinical Context: Inherited Cardiac Conditions and Sudden Death

Inherited cardiac conditions are a leading cause of sudden arrhythmic death syndrome (SADS) in individuals under 40. Conditions such as HCM, LQTS, Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT) are characterised by genetic mutations that predispose individuals to life-threatening arrhythmias. The clinical presentation may be unheralded, with sudden death as the first manifestation, or preceded by symptoms such as syncope, palpitations, or exertional chest pain.

Under NICE guidance (CG180: Familial hypercholesterolaemia: identification and management, 2014), when an inherited cardiac condition is identified or suspected in a deceased individual, first-degree relatives should be offered clinical and genetic screening. This process, known as cascade screening, aims to identify asymptomatic carriers who may benefit from risk stratification, lifestyle modification, pharmacological therapy, or implantable cardioverter-defibrillator (ICD) implantation. The failure to initiate or appropriately refer for cascade screening can have profound consequences, potentially leading to preventable deaths in at-risk family members.

Legal Relevance: The Duty to Screen and the Bolam/Bolitho Test

In clinical negligence claims involving alleged failures in family screening, the legal test for breach of duty is governed by the principles established in Bolam v Friern Hospital Management Committee [1957] and refined in Bolitho v City and Hackney Health Authority [1998]. The court must determine whether the clinician’s actions fell below the standard of a responsible body of medical opinion and, critically, whether that opinion is logically defensible.

In the context of inherited cardiac conditions, expert witnesses are often instructed to address:

• Whether the index event (e.g., sudden death) should have triggered suspicion of an inherited condition.
• Whether the deceased’s clinical presentation, family history, or post-mortem findings warranted referral to a specialist inherited cardiac conditions service.
• Whether the alleged failure to refer for cascade screening breached the standard of care expected of a reasonably competent clinician.
• The timing and appropriateness of genetic testing, including the role of molecular autopsy in cases of sudden death.

In fatal claims, the coronial process may also intersect with civil proceedings. A Prevention of Future Deaths (PFD) report under paragraph 7 of Schedule 5 to the Coroners and Justice Act 2009 may highlight systemic failures in family screening, which can inform the civil claim. Additionally, where the state’s obligations under Article 2 of the European Convention on Human Rights (ECHR) are engaged, the threshold for establishing breach may be heightened.

Comparing Expert Approaches: Methodology in Evaluating Screening Duty

Cardiology expert witnesses may adopt differing methodologies when assessing whether a breach of duty occurred in the context of family screening. These approaches can influence the strength of the claim and the expert’s conclusions on breach and causation. Below, we compare key aspects of expert methodology in this area.

1. Threshold for Suspicion of an Inherited Condition

Experts may diverge on the clinical features that should raise suspicion of an inherited cardiac condition. For example:

• Conservative Approach: Some experts argue that referral for specialist assessment should only occur where there is a clear family history of sudden death or a confirmed diagnosis of an inherited condition in a first-degree relative. This approach may emphasise the rarity of certain conditions and the potential for over-investigation.
• Proactive Approach: Other experts contend that any sudden death in a young individual, particularly in the absence of an obvious alternative cause, should prompt consideration of an inherited arrhythmia syndrome. This approach aligns with the “red flag” criteria outlined in international guidelines, such as those from the European Society of Cardiology (ESC).

In medico-legal practice, the expert’s stance on this threshold can significantly impact the assessment of breach. For instance, if an expert adopts a conservative approach, they may conclude that the absence of a family history justified the clinician’s decision not to refer. Conversely, a proactive expert may argue that the sudden death itself was sufficient to warrant specialist input, regardless of family history.

2. Role of Post-Mortem Findings

The interpretation of post-mortem findings is another area where expert opinions may differ. Key considerations include:

• Structural vs. Non-Structural Causes: Where post-mortem examination reveals structural abnormalities (e.g., HCM, ARVC), the duty to refer for family screening is generally uncontroversial. However, in cases of sudden arrhythmic death with a structurally normal heart (SADS), experts may disagree on whether the absence of structural findings negates the need for genetic testing or specialist referral.
• Molecular Autopsy: The role of post-mortem genetic testing (molecular autopsy) in cases of SADS is increasingly recognised. Some experts argue that molecular autopsy should be routine in all SADS cases, while others may advocate for a more selective approach, reserving genetic testing for cases with a suggestive family history or clinical phenotype.

In claims where the alleged breach relates to the failure to perform or recommend a molecular autopsy, the expert’s view on the utility and availability of such testing will be critical. Under CPR Part 35, the expert must provide an objective and unbiased opinion, grounded in the current evidence base.

3. Timeliness of Referral and Screening

The timing of referral for cascade screening can also be a contentious issue. Experts may differ on:

• Urgency of Referral: Some experts argue that referral should occur within weeks of the index event, particularly where there is a high suspicion of an inherited condition. Others may adopt a more lenient view, accepting delays of several months as reasonable, particularly in cases where the diagnosis is less clear.
• Follow-Up of At-Risk Relatives: The duty to ensure that at-risk relatives are actually screened may also be scrutinised. Experts may disagree on whether the clinician’s responsibility extends beyond making the referral to actively following up with the family.

In claims involving delays in referral, the expert’s assessment of the impact of the delay on outcomes (e.g., whether earlier screening would have identified an at-risk relative and prevented harm) will be central to the causation analysis.

Common Pitfalls and Disputes in Medico-Legal Practice

Several recurring issues arise in claims involving alleged breaches of the inherited cardiac condition screening duty. These include:

• Over-Reliance on Family History: Clinicians may fail to consider inherited conditions in the absence of a family history of sudden death. However, de novo mutations or incomplete penetrance can result in sporadic cases. Experts may dispute whether the absence of family history should have negated the duty to refer.
• Misinterpretation of Post-Mortem Findings: Non-specialist pathologists may overlook subtle structural abnormalities or fail to recognise the significance of a structurally normal heart in a young sudden death victim. Experts may critique the adequacy of the post-mortem examination or the interpretation of its findings.
• Failure to Escalate: Where initial investigations (e.g., ECG, echocardiogram) are inconclusive, experts may disagree on whether the clinician should have escalated to specialist input or genetic testing.
• Causation Challenges: Even where breach is established, proving causation can be difficult. Experts may differ on whether earlier screening would have altered the outcome for at-risk relatives, particularly where the condition has variable expressivity or incomplete penetrance.

In cases where breach and causation are disputed, the joint statement process under CPR Part 35.12 can be instrumental in clarifying areas of agreement and disagreement between experts. Solicitors should ensure that their expert is prepared to engage constructively in this process, focusing on the logical defensibility of their opinions under the Bolitho test.

The Role of the Expert Witness in Inherited Cardiac Condition Claims

In claims involving inherited cardiac conditions, the cardiology expert witness plays a multifaceted role, addressing both clinical and legal considerations. Key responsibilities include:

• Clinical Assessment: Reviewing the deceased’s medical records, post-mortem findings, and family history to determine whether the index event should have raised suspicion of an inherited condition.
• Guideline Compliance: Evaluating whether the clinician’s actions aligned with relevant guidelines, such as NICE CG180 or ESC recommendations on the management of inherited cardiac conditions.
• Breach Analysis: Applying the Bolam/Bolitho test to assess whether the clinician’s decisions fell below the standard of a responsible body of medical opinion.
• Causation: Addressing whether the alleged breach caused or materially contributed to the harm suffered by at-risk relatives. This may involve complex considerations of genetic risk, penetrance, and the efficacy of interventions such as ICD implantation.
• Quantum: In fatal claims, the expert may be asked to comment on the life expectancy of at-risk relatives had screening been initiated, as well as the psychological impact of the alleged breach.

For solicitors, selecting an expert with subspecialty expertise in inherited cardiac conditions is critical. General cardiologists may lack the nuanced understanding of genetic testing, cascade screening protocols, and the latest clinical guidelines required to provide a robust opinion in these cases. Additionally, the expert’s experience in medico-legal practice—particularly their familiarity with CPR Part 35 and the requirements of the court—can significantly influence the strength of their report.

Practical Guidance for Solicitors

For solicitors handling claims involving inherited cardiac conditions, the following considerations can help strengthen the case:

• Early Instruction of a Specialist Expert: Given the complexity of these cases, early instruction of a cardiology expert witness with subspecialty expertise in inherited cardiac conditions is advisable. This allows for timely review of medical records, post-mortem findings, and family history, as well as input on the viability of the claim.
• Focus on the Index Event: The expert’s assessment of whether the index event (e.g., sudden death) should have triggered suspicion of an inherited condition is often the linchpin of the claim. Solicitors should ensure that the expert addresses this threshold explicitly in their report.
• Scrutinise Post-Mortem Findings: Where the post-mortem examination was conducted by a non-specialist pathologist, consider obtaining a second opinion from a cardiac pathologist. Subtle abnormalities or the significance of a structurally normal heart may be overlooked by general pathologists.
• Address Causation Early: Causation can be a significant hurdle in these claims. Solicitors should ensure that the expert addresses not only whether breach occurred but also whether earlier screening would have altered the outcome for at-risk relatives.
• Prepare for Joint Statements: Given the potential for divergent expert opinions, solicitors should prepare their expert for the joint statement process. This includes ensuring that the expert’s opinions are logically defensible and grounded in the current evidence base.

In cases where the coronial process is ongoing, solicitors should also consider the potential impact of a PFD report on the civil claim. Early engagement with the coroner’s findings can help shape the civil case strategy.

Conclusion

The duty to initiate family screening following a sudden death from an inherited cardiac condition is a nuanced and evolving area of medico-legal practice. Expert witnesses may adopt differing approaches to assessing breach, particularly in cases where the clinical presentation is subtle or the family history is unremarkable. For solicitors, understanding these expert methodologies—and the potential pitfalls in claims of this nature—can be critical in building a robust case.

Specialist cardiology medico-legal assessment from an experienced consultant cardiologist expert witness can be pivotal in cases involving inherited cardiac conditions. Early instruction, careful selection of an expert with relevant subspecialty expertise, and a focus on both breach and causation are essential steps in navigating these complex claims.